These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30384141)

  • 1. Pharmacokinetic-pharmacodynamic integration of marbofloxacin after single and repeated intravenous administration in goats.
    Bhardwaj P; Sidhu PK; Lonare MK; Kaur R; Dumka VK; Rampal S
    Res Vet Sci; 2018 Dec; 121():111-115. PubMed ID: 30384141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic-pharmacodynamic relationship of marbofloxacin for Escherichia coli and Pasturella multocida following repeated intramuscular administration in goats.
    Bhardwaj P; Sidhu PK; Saini SPS; M B D; Rampal S
    J Vet Pharmacol Ther; 2019 Jul; 42(4):430-439. PubMed ID: 31102281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and pharmacodynamic integration and modelling of marbofloxacin in calves for Mannheimia haemolytica and Pasteurella multocida.
    Potter T; Illambas J; Pelligand L; Rycroft A; Lees P
    Vet J; 2013 Jan; 195(1):53-8. PubMed ID: 23084327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys.
    Haritova AM; Rusenova NV; Parvanov PR; Lashev LD; Fink-Gremmels J
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3779-85. PubMed ID: 16940071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic evaluation of marbofloxacin after intravenous administration at different ages in llama crias, and pharmacokinetic/pharmacodynamic analysis by Monte Carlo simulation.
    Rubio-Langre S; Aguilar-Sola S; Lorenzutti AM; San Andrés MI; De Lucas JJ; Litterio NJ
    J Vet Pharmacol Ther; 2018 Dec; 41(6):861-870. PubMed ID: 30020535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamics of marbofloxacin for calf pneumonia pathogens.
    Illambas J; Potter T; Cheng Z; Rycroft A; Fishwick J; Lees P
    Res Vet Sci; 2013 Jun; 94(3):675-81. PubMed ID: 23375665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling.
    Dorey L; Pelligand L; Lees P
    BMC Vet Res; 2017 Jul; 13(1):209. PubMed ID: 28666426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics/pharmacodynamics of marbofloxacin in a Pasteurella multocida serious murine lung infection model.
    Qu Y; Qiu Z; Cao C; Lu Y; Sun M; Liang C; Zeng Z
    BMC Vet Res; 2015 Dec; 11():294. PubMed ID: 26631082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic characterization of ceftiofur crystalline-free acid following subcutaneous administration in domestic goats.
    Waraich GS; Sidhu PK; Daundkar PS; Kaur G; Sharma SK
    J Vet Pharmacol Ther; 2017 Oct; 40(5):429-438. PubMed ID: 27943295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic behavior and pharmacokinetic/pharmacodynamic integration of marbofloxacin after subcutaneous administration in goats.
    Dova SW; San Andrés MD; González F; San Andrés MI; De Lucas JJ; Rodríguez C
    Vet J; 2007 Sep; 174(2):425-7. PubMed ID: 16807010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic/pharmacodynamic relationship of marbofloxacin against Pasteurella multocida in a tissue-cage model in yellow cattle.
    Shan Q; Wang J; Yang F; Ding H; Liang C; Lv Z; Li Z; Zeng Z
    J Vet Pharmacol Ther; 2014 Jun; 37(3):222-30. PubMed ID: 24033339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics, milk penetration and PK/PD analysis by Monte Carlo simulation of marbofloxacin, after intravenous and intramuscular administration to lactating goats.
    Lorenzutti AM; Litterio NJ; Himelfarb MA; Zarazaga MDP; San Andrés MI; De Lucas JJ
    J Vet Pharmacol Ther; 2017 Dec; 40(6):629-640. PubMed ID: 28470723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic testing of marbofloxacin administered as a single injection for the treatment of bovine respiratory disease.
    Vallé M; Schneider M; Galland D; Giboin H; Woehrlé F
    J Vet Pharmacol Ther; 2012 Dec; 35(6):519-28. PubMed ID: 22126438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of growth matrix on pharmacodynamics of antimicrobial drugs for pig pneumonia pathogens.
    Dorey L; Lees P
    BMC Vet Res; 2017 Jun; 13(1):192. PubMed ID: 28645327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of marbofloxacin in lactating cows after repeated intramuscular administrations and pharmacodynamics against mastitis isolated strains.
    Schneider M; Vallé M; Woehrlé F; Boisramé B
    J Dairy Sci; 2004 Jan; 87(1):202-11. PubMed ID: 14765828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro Dynamic Pharmacokinetic/Pharmacodynamic (PK/PD) study and COPD of Marbofloxacin against Haemophilus parasuis.
    Sun J; Xiao X; Huang RJ; Yang T; Chen Y; Fang X; Huang T; Zhou YF; Liu YH
    BMC Vet Res; 2015 Dec; 11():293. PubMed ID: 26626889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated pharmacokinetic-Pharmacodynamic (PK/PD) model to evaluate the in vivo antimicrobial activity of Marbofloxacin against Pasteurella multocida in piglets.
    Zeng QL; Mei X; Su J; Li XH; Xiong WG; Lu Y; Zeng ZL
    BMC Vet Res; 2017 Jun; 13(1):178. PubMed ID: 28619095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics and pharmacokinetic/pharmacodynamic evaluation of marbofloxacin against Coagulase-negative staphylococci, Staphylococcus aureus and Mycoplasma agalactiae pathogens in goats.
    Serrano-Rodríguez JM; Fernández-Varón E; Rodríguez CMC; Andrés-Larrea MIS; Rubio-Langre S; de la Fe C; Dova SW; Bhardwaj P; Sidhu PK; Litterio NJ; Lorenzutti AM
    Res Vet Sci; 2023 Jun; 159():1-10. PubMed ID: 37060837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Pasteurella multocida infection on the pharmacokinetic behavior of marbofloxacin after intravenous and intramuscular administrations in rabbits.
    Abo-el-Sooud K; Goudah A
    J Vet Pharmacol Ther; 2010 Feb; 33(1):63-8. PubMed ID: 20444027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida: Comparison of growth media.
    Dorey L; Hobson S; Lees P
    Res Vet Sci; 2017 Apr; 111():43-48. PubMed ID: 27940285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.